Imricor Medical Systems, Inc. (IMR.AX)
AUD 1.41
(-4.08%)
AUD 1.41
(-4.08%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | -1.11 Million AUD | 43.99% |
| 2022 | 16.46 Million USD | -14.0% |
| 2021 | 19.14 Million AUD | 58.16% |
| 2020 | 12.1 Million AUD | -6.96% |
| 2019 | 13.01 Million AUD | 69.21% |
| 2018 | 7.69 Million AUD | 10.21% |
| 2017 | 6.97 Million AUD | 17.5% |
| 2016 | 5.93 Million AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.76 Million USD | 2.19% |
| 2024 Q2 | 3.76 Million USD | 0.0% |
| 2023 Q1 | 4.23 Million USD | 23.02% |
| 2023 FY | 23.71 Million AUD | 43.99% |
| 2023 Q4 | 3.68 Million USD | -43.59% |
| 2023 Q3 | 6.52 Million USD | 53.92% |
| 2023 Q2 | 4.23 Million USD | 0.0% |
| 2022 FY | 16.46 Million USD | -14.0% |
| 2022 Q3 | 3.44 Million USD | -22.3% |
| 2022 Q2 | 4.43 Million USD | -0.0% |
| 2022 Q1 | 4.43 Million USD | 2.14% |
| 2022 Q4 | 3.44 Million USD | 0.0% |
| 2021 Q3 | 4.34 Million USD | -4.17% |
| 2021 Q4 | 4.34 Million USD | 0.0% |
| 2021 Q2 | 4.53 Million USD | 0.0% |
| 2021 FY | 19.14 Million AUD | 58.16% |
| 2021 Q1 | 4.53 Million USD | 45.53% |
| 2020 Q1 | 2.77 Million USD | -30.93% |
| 2020 Q3 | 3.11 Million USD | 12.17% |
| 2020 Q2 | 2.77 Million USD | 0.0% |
| 2020 Q4 | 3.11 Million USD | 0.0% |
| 2020 FY | 12.1 Million AUD | -6.96% |
| 2019 Q1 | 2.25 Million USD | 59.95% |
| 2019 FY | 13.01 Million AUD | 69.21% |
| 2019 Q4 | 4.01 Million USD | 0.0% |
| 2019 Q3 | 4.01 Million USD | 78.48% |
| 2019 Q2 | 2.25 Million USD | 0.0% |
| 2018 Q3 | 1.4 Million USD | -1.19% |
| 2018 Q1 | 1.42 Million USD | 0.0% |
| 2018 Q2 | 1.42 Million USD | 0.0% |
| 2018 Q4 | 1.4 Million USD | 0.0% |
| 2018 FY | 7.69 Million AUD | 10.21% |
| 2017 FY | 6.97 Million AUD | 17.5% |
| 2016 FY | 5.93 Million AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| 4DMedical Limited | 31.48 Million AUD | 103.544% |
| Adherium Limited | 267.7 Thousand AUD | 516.82% |
| Aroa Biosurgery Limited | 66.09 Million AUD | 101.688% |
| Atomo Diagnostics Limited | 1.6 Million AUD | 169.479% |
| Anteris Technologies Ltd | 69.14 Million AUD | 101.614% |
| Control Bionics Limited | 9.82 Million AUD | 111.356% |
| CardieX Limited | 16.64 Million AUD | 106.702% |
| Compumedics Limited | 26.88 Million AUD | 104.151% |
| Cochlear Limited | 1.17 Billion AUD | 100.095% |
| CleanSpace Holdings Limited | 11.35 Million AUD | 109.823% |
| Cyclopharm Limited | 13.38 Million AUD | 108.339% |
| EMVision Medical Devices Ltd | 12.83 Million AUD | 108.695% |
| Nova Eye Medical Limited | 23.99 Million AUD | 104.651% |
| HeraMED Limited | 6.78 Million AUD | 116.451% |
| ImpediMed Limited | 28.04 Million AUD | 103.979% |
| InhaleRx Limited | 2.59 Million AUD | 143.074% |
| LBT Innovations Limited | 1.1 Million AUD | 200.798% |
| Micro-X Limited | 18.76 Million AUD | 105.947% |
| Neurotech International Limited | 8.75 Million AUD | 112.746% |
| OncoSil Medical Limited | 12.03 Million AUD | 109.268% |
| PolyNovo Limited | 34.92 Million AUD | 103.195% |
| Respiri Limited | 8.03 Million AUD | 113.887% |
| SomnoMed Limited | 58.97 Million AUD | 101.892% |
| Universal Biosensors, Inc. | 20 Million AUD | 105.579% |
| Uscom Limited | 5.52 Million AUD | 120.214% |
| Visioneering Technologies, Inc. | 9.63 Million AUD | 111.583% |